Robert N. Wilson, Director at SYNTA PHARMACEUTICALS CORP (SNTA), bought 50,000 shares at $4.89 ($244K) on 2011-04-14, disclosed to the SEC on 2011-04-18.
Open-market purchase of $244k SNTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CALC | BUY | 2024-08-26 | $201K | — | Filing → |
| CALC | BUY | 2024-07-02 | $361K | — | Filing → |
| CALC | BUY | 2024-07-01 | $27K | — | Filing → |